Literature DB >> 15860566

Time-motion analysis of 6 cystic fibrosis mutation detection systems.

Amy E Krafft1, Jack H Lichy.   

Abstract

BACKGROUND: A dramatic increase in requests for routine cystic fibrosis (CF) carrier screening prompted us to conduct a time-motion analysis comparing commercially available CF testing platforms. Questions addressed in the study included: (a) How much time is required to perform each step involved in carrying out the assay procedure? (b) Which system requires the minimum number of manual manipulations to complete a typical run? (c) What workflow benefits can be achieved by automation?
METHODS: We used a 96-sample run for comparisons and analyzed each of the 6 methods to determine the number of pipetting steps and manual manipulations, the labor and instrument time, and the total time required to perform the assay. The survey participants included a staff of 4 technologists who perform complex molecular assays regularly. Time required for each procedure was determined by direct observation and from work logs completed by the technologists.
RESULTS: The total number of pipetting motions varied from 78 to 344. Labor time ranged from 2.6 to 8.4 h, and total assay time from 7.6 to 13.7 h.
CONCLUSION: Time-motion analysis allowed identification of a method that minimized pipetting motions and thus reduced the risk of repetitive stress injury.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15860566     DOI: 10.1373/clinchem.2004.047423

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  4 in total

1.  Comparison of amplicon-sequencing, pyrosequencing and real-time PCR for detection of YMDD mutants in patients with chronic hepatitis B.

Authors:  Zhi-Jun Yang; Mei-Zeng Tu; Jian Liu; Xiao-Ling Wang; Hong-Zhi Jin
Journal:  World J Gastroenterol       Date:  2006-11-28       Impact factor: 5.742

2.  A comparative study of five technologically diverse CFTR testing platforms.

Authors:  Monique A Johnson; Marvin J Yoshitomi; C Sue Richards
Journal:  J Mol Diagn       Date:  2007-07       Impact factor: 5.568

3.  Rapid one-step carrier detection assay of mucolipidosis IV mutations in the Ashkenazi Jewish population.

Authors:  Feras M Hantash; Susan C Olson; Ben Anderson; Arlene Buller; Rebecca Chen; Beryl Crossly; Weimin Sun; Charles M Strom
Journal:  J Mol Diagn       Date:  2006-05       Impact factor: 5.568

4.  Oligonucleotide chip, real-time PCR and sequencing for genotyping of hepatitis B virus.

Authors:  Yong-Zhong Wang; Guo-Xiang Wu; Li-Bo Luo; Min Chen; Li-Hua Ruan
Journal:  World J Gastroenterol       Date:  2007-08-21       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.